IBIO (iBio Inc) Net Profit

IBIO (iBio) - company brandmark

Is it worth investing in iBio, Inc. (IBIO), whose management is pivoting the business toward AI-driven antibody development? On GURU.Markets, the company's annual financial results provide the answer, where the value of -0.03 reflects this status. The brand's high authority in oncology is based on the accuracy of precision engineering; however, the lack of commercial products leaves its financial health dependent on external grants and investments.

IBIO (iBio, Inc.) Net Profit history from 07/04/2022 to 10/30/2026

Analytical breakdowns and data insights for company iBio (IBIO)

- price and consensus price forecast:
Stock Quotes iBio Corporation|IBIO - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization iBio Corporation|IBIO - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share iBio|IBIO - Book Capitalization|Market Capitalization to Book Value ibioinc.com|IBIO - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio iBio, Inc.|IBIO - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio iBio Inc|IBIO - Company Total Debt|Debts to Book Capitalization iBio Corporation|IBIO - Company Long-Term Debt|Company Short-Term Indebtedness iBio|Immediate Liquidity ibioinc.com
- net income and valuation multiples indicators:
IBIO - Net Profit
Summary company analysis:iBio, Inc.
Core merchandise of iBio Corp

This indicator objectively measures the equity value of operating income, synthesizing quarterly reports into a continuous daily data stream for fundamental valuation. By analyzing the earnings of iBio, Inc. (IBIO), an investor can observe the financial return from utilizing the AI platform in the development of cancer therapy antibodies, enabling an assessment of the monetization of biotechnological collaborations and the risks of acquiring the asset at local peaks.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|Net Financial Result Pharming Corp PHAR|NKTR: Net Profit|UPB (upstreambio.com) - Company Net Income|ZBIO (Zenas Biopharma) - Net Profit|Immunome Inc (IMNM) - Net Financial Result|Company Net Income Gossamer Corp (GOSS)|KALV - Company Net Income|Septerna Inc - Net Income|Final Profit PVLA|Savara - Net Profit|Net Financial Result Rigel Pharma RIGL|AnaptysBio Corp (ANAB) - Company Net Income|Company Profit ATXS|ENGN (enGene Holdings Inc.) - Net Profit|Net Income rapt.com (RAPT)|Net Income JBIO (Aerovate Therapeutics Inc)|Net Financial Result Aclaris Therapeutics Inc.|Net Profit KYTX (Kyverna)|Net Financial Result Tiziana Life Sciences, Ltd. (TLSA)|Cabaletta Bio, Inc. - Net Profit|VTYX: Company Net Income|THTX: Net Profit|AVTX - Net Financial Result|Company Net Income Eledon|Company Net Income Agenus, Inc AGEN|Company Net Income Climb Bio Inc (CLYM)|ZURA: Profit After Tax|Net Profit ATYR (aTyr Pharma)|Final Profit ADAG|Ikena Oncology, Inc. - Net Profit|STTK - Net Profit|equilliumbio.com (EQ) - Company Net Income|Connect Biopharma Holdings Limited - Final Profit|Company Net Income Immunic Therapeutics|Net Income Atara Biotherapeutics Inc (ATRA)|Net Profit IFRX|Net Profit X4 Pharmaceuticals, Inc (XFOR)|Adicet Bio, Inc. - Net Income|Final Profit CELU|INmune Bio - Net Profit|Net Financial Result Barinthus Biotherapeutics PLC BRNS|Kezar Life Sciences, Inc (KZR) - Company Net Income|Net Income SAB Biotherapeutics Inc|Company Net Income Akari Therapeutics|Net Income Enlivex Therapeutics, Ltd. (ENLV)|Net Income QTTB (Q32 Bio Inc.)|Net Profit GeoVax Labs (GOVX)|Company Net Income Edesa EDSA|CARM: Company Profit|XTL Biopharmaceuticals - Net Profit|Company Net Income Bolt Biotherapeutics|HCWB: Net Profit|APVO - Net Financial Result|AIM (AIM ImmunoTech) - Net Profit|Company Net Income ADTX|Net Profit GRI|Net Financial Result xortx.com|Company Net Income Vyome Holdings HIND|Revelation Biosciences Inc (REVB) - Company Net Income|INDP: Net Income|Final Profit SCNI (BiondVax Pharmaceuticals)|CALI: Net Profit|AFMD - Net Financial Result|Company Net Income Allakos Inc|Company Profit HOOK (HOOKIPA)|Net Profit IGMS|Net Income iTeos Pharma ITOS|Ocean Biomedical, Inc. - Net Income|Net Financial Result tcbiopharm.com (TCBP)|Third Harmonic Bio, Inc. - Net Profit